Clonmel Healthcare Limited PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd. STADA Arzneimittel AG

The medicine is intended for adult men with prostate cancer. It is used when the tumor does not respond to hormonal therapy or surgical treatment aimed at reducing testosterone levels, when the cancer has spread to other parts of the body, or in men after prostate removal or radiation therapy who experience a rapid increase in PSA levels.

Dosage form: tablets, film-coated

ATC: L02BB04